Literature DB >> 8275489

Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread.

H Tsuda1, D F Callen, T Fukutomi, Y Nakamura, S Hirohashi.   

Abstract

Loss of heterozygosity on chromosomal arm 16q has been shown to be a frequent event in sporadic breast cancer and is suggested to be involved in cancer development through inactivation of a tumor-suppressor gene. To specify the commonly deleted region in which the unknown tumor-suppressor gene is located, a deletion map of chromosome 16 was constructed for 78 breast cancers, using 27 polymorphic DNA markers. Loss of heterozygosity on chromosome 16q was detected in 38 of the tumors. From the deletion map, the incidence of the loss of heterozygosity was deduced to be > or = 36% in the region distal to 16q12 and was most frequent in the 16q24.2-qter region. Then, association of the loss of heterozygosity in the 16q24.2-qter region with clinicopathological parameters of the tumors was examined for a total of 234 tumors, to reveal its biological significance in breast cancer development. The total incidence of loss of heterozygosity in the 16q24.2-qter region was 52% (118 of 225), and loss of heterozygosity was frequent irrespectively of the presence of invasion and metastasis, differences in clinical stage, tumor size, histological grade, or type, or amounts of estrogen receptor. Inactivation of an unknown tumor-suppressor gene on 16q24.2-qter was thus suggested to be involved commonly in the genesis of sporadic breast cancer, irrespectively of the extent of tumor spread or grade of aggressiveness of the cancer cells. On the other hand, eight cases revealed loss of heterozygosity not at 16q24-qter but in more proximal regions. Therefore, it appears that multiple tumor-suppressor genes are located on chromosome 16q.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8275489

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

1.  Low Frequency Loss of Heterozygosity in the BRCA1 Region in Japanese Sporadic Breast Cancer.

Authors: 
Journal:  Breast Cancer       Date:  1996-12-20       Impact factor: 4.239

2.  Detection of numerical and structural alterations and fusion of chromosomes 16 and 1 in low-grade papillary breast carcinoma by fluorescence in situ hybridization.

Authors:  H Tsuda; T Takarabe; N Susumu; J Inazawa; S Okada; S Hirohashi
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

3.  Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas.

Authors:  K M Rieger-Christ; J A Pezza; J M Dugan; J W Braasch; K S Hughes; I C Summerhayes
Journal:  Mol Pathol       Date:  2001-04

4.  Loss of heterozygosity on chromosome 16q suggests malignancy in core needle biopsy specimens of intraductal papillary breast lesions.

Authors:  Miwa Yoshida; Hitoshi Tsuda; Sohei Yamamoto; Takayuki Kinoshita; Sadako Akashi-Tanaka; Takashi Hojo; Takashi Fukutomi
Journal:  Virchows Arch       Date:  2012-04-04       Impact factor: 4.064

5.  A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGH.

Authors:  R Roylance; P Gorman; T Papior; Y-L Wan; M Ives; J E Watson; C Collins; N Wortham; C Langford; H Fiegler; N Carter; C Gillett; P Sasieni; S Pinder; A Hanby; I Tomlinson
Journal:  Oncogene       Date:  2006-05-15       Impact factor: 9.867

6.  Recessive oncogenes: current status.

Authors:  Xiang Gao; Kenneth V Honn
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

7.  Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor status.

Authors:  María I Nunez; John Ludes-Meyers; Martín C Abba; Hyunsuk Kil; Nancy W Abbey; Robert E Page; Aysegul Sahin; Andrés J P Klein-Szanto; C Marcelo Aldaz
Journal:  Breast Cancer Res Treat       Date:  2005-01       Impact factor: 4.872

8.  Multiplex loss of heterozygosity analysis by using single or very few cells.

Authors:  Xiangfeng Cui; Helen Feiner; Honghua Li
Journal:  J Mol Diagn       Date:  2002-08       Impact factor: 5.568

9.  Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation.

Authors:  Kiyomi O Toyooka; Shinichi Toyooka; Anirban Maitra; Qinghua Feng; Nancy C Kiviat; Alice Smith; John D Minna; Raheela Ashfaq; Adi F Gazdar
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

10.  Characterization of an HPV-negative cell line (FR-CAR) derived from a cervical squamous intraepithelial lesion.

Authors:  C van Haaften-Day; B Rose; C Thompson; R Lukeis; P Russell
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-10       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.